Mounjaro®
Starting from £179.99/mo
Start journey Learn moreBruising at the injection site after a Wegovy shot is common and almost always harmless. It happens when a small blood vessel is nicked during the injection, leaving a tender patch that fades within a few days. That said, some people report bruising more easily in general on semaglutide, which is worth understanding. These are prescription-only medicines; a prescriber assesses suitability before treatment starts.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people who notice a dark patch after their Wegovy shot assume they've made an error, used the wrong technique, or that the medicine itself has damaged the tissue. In reality, a small bruise is simply a skin capillary being nicked by the needle. It says nothing about whether the dose was absorbed correctly or whether the medicine is working. The semaglutide in Wegovy is absorbed into subcutaneous fat, not into a blood vessel, so a surface bruise has no effect on the dose you receive.
The skin on the abdomen and thighs (the most common injection areas) is crossed by a fine network of tiny blood vessels. Any needle, regardless of its gauge, can occasionally clip one. This is true of all subcutaneous injections, from insulin to heparin. Feeling briefly alarmed when you spot a bruise is understandable; it looks worse than it is.
According to the NHS patient information for semaglutide, injection-site reactions including bruising, redness and swelling are listed among the common effects of this class of medicine.
A few practical factors increase the chance of bruising after any subcutaneous injection. Injecting into the same spot repeatedly is the main culprit. The tissue never fully recovers between doses if you always use the same centimetre of skin, and repeated micro-trauma builds up. Rotating properly (moving at least two to three centimetres from the previous site, and cycling between abdomen, thigh and upper arm across weeks) makes a measurable difference.
Speed of insertion and angle matter too. A confident, swift entry at the angle recommended in the Patient Information Leaflet displaces rather than tears tissue. Hesitating partway in or withdrawing at an awkward angle can drag across capillaries. Some people also find that letting the pen warm to room temperature for a few minutes before injecting reduces the sting and the likelihood of a bruise, though the evidence for this is mainly practical rather than trial-based.
Certain medications thin the blood or affect platelet function: aspirin, ibuprofen, warfarin, apixaban and even high-dose fish-oil supplements. If you take any of these, bruising may be more pronounced. Let your prescriber know, it is relevant context, not a disqualifying detail.
For a broader look at what the Wegovy injection schedule involves, our page on bruising from a semaglutide shot covers the practical technique points in more detail.
There is a distinction between localised injection-site bruising and noticing that you bruise easily in general: bumping a table edge and finding a large bruise, or bruises appearing with no clear cause. If you want to understand more about bruising with Wegovy, including why some people seem more prone to it than others, our dedicated page goes into that in more detail.
Generalised easy bruising has many potential causes beyond medication: nutritional deficiencies (particularly vitamins C and K), reduced caloric intake affecting micronutrient levels, changes in body composition as fat tissue thins, or pre-existing conditions the medicine has simply coincided with. On a calorie-reduced diet alongside Wegovy treatment, ensuring adequate nutrition matters. If you have concerns about bruising easily on semaglutide more broadly, that is a conversation for your prescriber rather than something to troubleshoot alone.
The MHRA Yellow Card scheme exists for patients to report any suspected side effects they believe are linked to a medicine, including unexpected bruising patterns. Reports from real patients have contributed to what we understand about GLP-1 medicines, so the scheme is worth using if you notice something that feels disproportionate.
Most injection-site bruises need nothing: leave them alone, avoid pressing on the area, and move your next injection site. A cold pack in the first hour can reduce swelling if the bruise is particularly tender.
Seek medical advice if a bruise is expanding rather than fading after 48 hours, if the surrounding skin becomes hot, red and increasingly painful (which could suggest infection rather than bruising), or if you notice bruising developing without any clear cause across multiple body sites simultaneously. These are not typical of a Wegovy injection response.
If you are on blood-thinning medicines and bruising is becoming frequent or very large, raise it at your next clinical review rather than adjusting your medication independently. For questions about how Wegovy treatment is managed over time, including what a stop in treatment means for weight, our prescribers review each patient individually before every repeat order.
Thinking about starting Wegovy or switching from another provider? Our page on accessing Wegovy through a regulated UK pharmacy explains the clinical assessment process.
If you have noticed bruising that's worrying you or have questions about your injection technique, speak to our prescribers, every consultation is reviewed the same day by a named, GPhC-registered clinician, not a system.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.